metastatic/advanced - colorectal cancer (mCRC) | |
metastatic/advanced - colorectal cancer (mCRC) | |
atezolizumab plus SoC | Modul Cohort 2 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -